Epilepsi, feberkramper

Alvestad S, Husebye ESN, Dreier JW, Sun Y, Igland J, Leinonen MK et al Folic acid and risk of preterm birth, preeclampsia, and fetal growth restriction among women with epilepsy, Neurology 2022;99 (6).

Engelsen BA, Tzoulis C, Karlsen B, Lillebø A, Laegreid LM, Aasly J, Zeviani M, Bindoff LA. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008 Mar;131(Pt3):818-28

Knake S, Hamer HM, Rosenow F. Status epilepticus: A critical review. Epilepsy Behav 2009 Feb 21. [Epub ahead of print]

Willmore LJ, Abelson MB, Ben-Menachem E, Pellock JM, Shields WD. Vigabatrin: 2008 update. Epilepsia. 2009 Feb;50(2):163-73

Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: Analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res 2009; Mar 25. [Epub ahead of print]

Shorvon S, Baulac M, Cross H, Trinka E, Walker M. Task force on status epilepticus of the ILAE Commission for European Affairs. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia. 2008 Jul;49(7):1277-85

Uges JW, van Huizen MD, Engelsman J, Wilms EB, Touw DJ, Peeters E, Vecht CJ. Safety and pharmacokinetics of intravenous levetiracetam infusion as add-on in status epilepticus. Epilepsia, 2009 Mar;50(3):415-21

Westin AA, Reimers A, Helde G, Nakken KO, Brodtkorb E. Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure. 2008 Mar; 17(2):192-8

Wheless JW, Clarke D, Hovinga CA, Ellis M, Durmeier M, McGregor A, Perkins F. Rapid Infusion of a Loading Dose of Intravenous Levetiracetam With Minimal Dilution: A Safety Study. J Child Neurol. 2009 Mar 4. [Epub ahead of print]

Wheless JW, Treiman DM. The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus. Epilepsia. 2008;49 Suppl 9:74-8

Berg et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010 Apr;51(4):676-85

Berg AT, Cross JH. Towards a modern classification of the epilepsies? Lancet Neurol. 2010 May;9(5):459-61

Tomson et al. Dose dependent risk of malformations with antiepileptic drugs; an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17

Retningslinjer for behandling av kvinner med epilepsi. Konsensusrapport 2011. Den norske legeforening

Veileder i akuttnevrologi. Norsk nevrologisk forening. Kvalitetsutvalget 2014  

Oluwabusi T, Sood SK. Update on the management of simple febrile seizures: emphasis on minimal intervention. Curr Opin Pediatr 2012;24 (e-pub ahead of print)

Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC; Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010 Mar 4;362(9):790-9.  

Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology. 2009 Sep 29;73(13):1041-5.  

Abend NS, Bearden D, Helbig I, McGuire J, Narula S, Panzer JA, Topjian A, Dlugos DJ. Status epilepticus and refractory status epilepticus management. Semin Pediatr Neurol. 2014 Dec;21(4):263-74.  

Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015 Apr 20. pii: S1474-4422(15)00042-3. doi: 10.1016/S1474-4422(15)00042-3. [Epub ahead of print]  

Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012 Aug;17(1):3-23.  

https://www.ema.europa.eu/en/news/prac-recommends-new-measures-avoid-valproate-exposure-pregnancy 

https://www.ema.europa.eu/en/news/prac-starts-review-topiramate-use-pregnancy-women-childbearing-potential 

NICE (National Institute for Care and Health Excellence) Guidelines http://pathways.nice.org.uk/pathways/epilepsy  

Norsk elektronisk legehåndbok (NEL) 2015: Status epilepticus  

Syndi Seinfeld D, Pellock JM. Recent Research on Febrile Seizures: A Review. J Neurol Neurophysiol. 2013 Sep 25;4(165). pii: 19519.  

Helsidirektoratet. Førerkort – veileder til helsekrav (gjeldende fra 1. oktober 2016)  

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010 Jun;51(6):1069-77

Kunnskapsbasert retningslinje om epilepsi https://www.epilepsibehandling.no/index.php (sist lest 16.05.2023.)  

Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus le-vetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021;10;397(10282):1375-1386. 

Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton C, Hughes DA, Williamson P, Baker GA, Balabanova S, Taylor C, Brown R, Hindley D, How-ell S, Maguire M, Mohanraj R, Smith PE; SANAD II collaborators. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, ran-domised controlled trial. Lancet. 2021;10;397(10282):1363-1374. 

Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE. Lamotrigine versus levetiracetam or zonisam-ide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD IInon-inferiority RCTs. Health Technol Assess. 2021;25(75):1-134.

Reimers A, Berg JA, Burns ML, Landmark CJ. Felles referanseområder for antiepileptika. Tidsskr Nor Laegeforen. 2017 Jun 26;137(12-13):864-865

Retningslinjer for behandling av kvinner med epilepsi. Konsensusrapport 2017. https://www.legeforeningen.no/om-oss/publikasjoner/retningslinjer/retningslinjer-for-behandling-av-kvinner-med-epilepsi-2018/

Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, et al. NETT investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 2012;366:591–600.  

Strzelczyk A, Steinig I, Willems LM, Reif PS, Senft C, Voss M, Gaida B, von Podewils F, Rosenow F. Treatment of refractory and super-refractory status epilepticus with brivaracetam: A cohort study from two German university hospitals. Epilepsy Behav. 2017 May;70(Pt A):177-181  

Veileder i akuttnevrologi. Norsk nevrologisk forening. Kvalitetsutvalget 2019 NEL - Norsk Elektronisk Legehåndbok (legehandboka.no)

Migrene

Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009;16:968-81

Multippel sklerose

Diagnostikk, attakk- og sykdomsmodifiserende behandling av multippel sklerose, Nasjonale faglige retningslinjer, Helsedirektoratet 2017 [IS–2637]

Norsk MS-veileder. Nasjonal komptansetjeneste for multippel sklerose (MS) 2016

Klasehodepine

Francis Gj, Becker WJ, Pringsheim TM. Acute and preventive pharmacologic treatment of cluster headache. Neurology 2010;75:463-73

Cohen AS, Burns B, Goadsby PJ. High-flow oxygen treatment of cluster headache: a randomized trial. JAMA 2009;302:2451-57

Rozen TD, Fishman RS. Cluster headache in the United States of America: demographics, clinical characteristics, triggers, suicidality, and personal burden. Headache 2012;52:99-113

May A, Leone M, Afra J, Linde M, Sándor PS, Evers G, Goadsby PJ. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalagias. Eur J Neurol 2006;13:1006-77

Parkinsons sykdom

PD MED Collaborative Group: Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet 2014;384:1196-205

Spenningshodepine

Bendtsen L, Evers S, Linde M, Mitsikostas DD, Sandrini G, Schoenen J. EFNS guideline on the treatment of tension-type headache - report of an EFNS task force. Eur J Neurol 2010; 17:1318-25

Legemiddelutløst hodepine

Evers S, Jensen R. Treatment of medication overuse headache - guideline of the EFNS headache panel. Eur J Neurol 2011; 18:1115-21

Trigeminusnevralgi

Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17:113-23

Mueller D, Obermann M, Yoon MS, Poitz F, Hansen N, Slomke MA, Dommes P, Gizewski E, Diener HC, Katsarava Z. Prevalence of trigeminal neuralgia and persistent idiopathic facial pain: a population-based study. Cephalalgia 2011;31:1542-8